AGIO vs NTAP · rev $65.5M vs P/E 28, rev $6.24B
Agios Pharm (AGIO) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
AGIO currently screens at market cap $1.68B. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the AGIO and NTAP stock pages for the full models.
Not investment advice.